Pharma Financial Statements From 2010 to 2024
| PBSV Stock | USD 0.61 0.11 22.00% |
Check Pharma Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharma Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Pharma financial statements analysis is a perfect complement when working with Pharma Bio Valuation or Volatility modules.
Pharma |
Pharma Bio Serv OTC Stock Return On Equity Analysis
Pharma Bio's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pharma Bio Return On Equity | 0.0568 |
Most of Pharma Bio's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharma Bio Serv is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Pharma Bio Serv has a Return On Equity of 0.0568. This is 100.24% lower than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is 118.32% lower than that of the firm.
Pharma Bio Serv Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharma Bio's current stock value. Our valuation model uses many indicators to compare Pharma Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharma Bio competition to find correlations between indicators driving Pharma Bio's intrinsic value. More Info.Pharma Bio Serv is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pharma Bio Serv is roughly 1.72 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharma Bio's earnings, one of the primary drivers of an investment's value.About Pharma Bio Financial Statements
Pharma Bio investors use historical fundamental indicators, such as Pharma Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pharma Bio. Please read more on our technical analysis and fundamental analysis pages.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharma OTC Stock Analysis
When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.